Hyperbaric oxygen therapy alleviates vascular dysfunction and amyloid burden in an Alzheimer’s disease mouse model and in elderly patients

Degenerative Disease

We exposed elderly patients with significant memory loss at baseline to HBOT and observed an increase in CBF and improvement in cognitive performances. This study demonstrates HBOT efficacy in hypoxia-related neurological conditions, particularly in AD and aging.

Source:

Team

Learn more about the team from BioxyTran

Investors

Learn more about BioxyTran investors and S1 Stocks

Forum

Join the conversation as we discuss Bioxytran's use-cases,
development progress, and more.